These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26424269)

  • 41. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W; Obeid OE; Steward MW
    Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs.
    Tarradas J; Monsó M; Muñoz M; Rosell R; Fraile L; Frías MT; Domingo M; Andreu D; Sobrino F; Ganges L
    Vaccine; 2011 Jun; 29(26):4422-9. PubMed ID: 21496472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel method for enhancement of peptide vaccination utilizing T-cell epitopes from conventional vaccines.
    Yano A; Miwa Y; Kanazawa Y; Ito K; Makino M; Imai S; Hanada N; Nisizawa T
    Vaccine; 2013 Mar; 31(11):1510-5. PubMed ID: 23318151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Linear B-cell epitope mapping using enzyme-linked immunosorbent assay for libraries of overlapping synthetic peptides.
    Heuzenroeder MW; Barton MD; Vanniasinkam T; Phumoonna T
    Methods Mol Biol; 2009; 524():137-44. PubMed ID: 19377942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenicity comparison of a multi-antigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB9 protein in mice.
    Cruz LJ; Quintana D; Iglesias E; Garcia Y; Huerta V; Garay HE; Duarte C; Reyes O
    J Pept Sci; 2000 May; 6(5):217-24. PubMed ID: 10823490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequential order of T and B cell epitopes affects immunogenicity but not antibody recognition of the B cell epitope.
    Denton G; Hudecz F; Kajtár J; Murray A; Tendler SJ; Price MR
    Pept Res; 1994; 7(5):258-64. PubMed ID: 7531518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peptides designed to spatially depict the Epstein-Barr virus major virion glycoprotein gp350 neutralization epitope elicit antibodies that block virus-neutralizing antibody 72A1 interaction with the native gp350 molecule.
    Tanner JE; Coinçon M; Leblond V; Hu J; Fang JM; Sygusch J; Alfieri C
    J Virol; 2015 May; 89(9):4932-41. PubMed ID: 25694592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides.
    Ferguson M; Reed SE; Minor PD
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2527-31. PubMed ID: 2431104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group.
    Motté P; Alberici G; Ait-Abdellah M; Bellet D
    J Immunol; 1987 May; 138(10):3332-8. PubMed ID: 2437187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses.
    Nagata T; Toyota T; Ishigaki H; Ichihashi T; Kajino K; Kashima Y; Itoh Y; Mori M; Oda H; Yamamura H; Taneichi M; Uchida T; Ogasawara K
    Vaccine; 2007 Jun; 25(26):4914-21. PubMed ID: 17531358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A.
    Wu HC; Yeh CT; Huang YL; Tarn LJ; Lung CC
    Appl Environ Microbiol; 2001 Jul; 67(7):3201-7. PubMed ID: 11425742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12.
    Karpenko LI; Scherbakova NS; Chikaev AN; Tumanova OY; Lebedev LR; Shalamova LA; Pyankova OG; Ryzhikov AB; Ilyichev AA
    Mol Immunol; 2012 Apr; 50(4):193-9. PubMed ID: 22341130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of Peptide Antibodies by Epitope Mapping Using Resin-Bound and Soluble Peptides.
    Trier NH
    Methods Mol Biol; 2024; 2821():179-193. PubMed ID: 38997489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epitope identification of specific naturally occurring human anti-avidin antibodies.
    Tchernychev B; Miron T; Wilchek M
    Immunol Lett; 2018 Apr; 196():119-123. PubMed ID: 29175317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipid matrix-based vaccines for mucosal and systemic immunization.
    Mannino RJ; Gould-Fogerite S
    Pharm Biotechnol; 1995; 6():363-87. PubMed ID: 7551226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of anti-peptide and anti-protein sera. Effect of peptide presentation on immunogenicity.
    McLean GW; Owsianka AM; Subak-Sharpe JH; Marsden HS
    J Immunol Methods; 1991 Mar; 137(2):149-57. PubMed ID: 1707429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Production and characterization of antibodies against synthetic peptides.
    Hancock DC; Evan GI
    Methods Mol Biol; 1998; 80():15-22. PubMed ID: 9664360
    [No Abstract]   [Full Text] [Related]  

  • 58. Production of epitope-specific antibodies using peptide-CpG-ODN-liposome complex without carriers and their application as a cancer vaccine in mice.
    Lee Y; Kwon HJ
    Oncoimmunology; 2012 Oct; 1(7):1215-1217. PubMed ID: 23170285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural Characterization of Peptide Antibodies.
    Chailyan A; Marcatili P
    Methods Mol Biol; 2015; 1348():205-14. PubMed ID: 26424274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptide Antibodies: Current Status.
    Houen G
    Methods Mol Biol; 2024; 2821():1-8. PubMed ID: 38997476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.